Study Explores Approaches to Addressing Lymphatic Pain in Breast Cancer Survivors
Among the 7.8 million women with breast cancer worldwide, at least 33% to 44% are affected by lymphatic pain. Breast cancer survivors usually suffer lymphatic pain in the ipsilateral body or upper limb, and pharmacological approaches are not effective for lymphatic pain.
In a recent publication in Women and Children Nursing, a group of researchers from the United States and Spain further deepened our understanding of this particular type of pain through evidence-based knowledge and insights into precision assessment and therapeutic behavioral intervention.
“Historically, the concept of cancer-related pain has been used to study chronic pain associated with cancer or cancer treatment. Cancer-related pain refers to persistent pain that continues more than three months after active cancer treatment,” says lead author, Jeanna Qiu, a MD-PhD student at Harvard Medical School. “Conventional research on chronic cancer pain focuses on the occurrence and severity of general bodily pain in any body location. This approach has not been able to distinguish different types of pain after cancer treatment, such as lymphatic pain due to fluid accumulation and inflammation, general bodily pain, postmastectomy pain, chemotherapy-induced peripheral neuropathy, or arthralgias related to hormonal treatments.”
Hence, opportunities are missed when it comes to investigating the underlying physiological and psychosocial mechanisms of different types of pain and developing efficacious pain treatments.
To that end, the team provided evidence for the etiology of lymphatic pain, conducted objective and subjective assessments of lymphatic pain, and further offered evidence for effective behavioral interventions to promote lymph flow and reduce inflammation for lymphatic pain.
According to co-first author Mei Fu, at Dorothy and Dale Thompson Missouri Endowed Professor in Nursing and Associate Dean for Research at the University of Missouri-Kansas City School of Nursing and Health Studies, the study provided much-needed knowledge regarding precision assessment that enables clinicians to distinguish different types of pain.
“Detailed evidence also underscored the effectiveness of behavioral interventions to promote lymph flow, such as The-Optimal-Lymph-Flow program,” says Fu. “The comprehensive knowledge and evidence in this study can be directly applied to clinical practice to reduce lymphatic pain in women treated for breast cancer to reduce lymphatic pain.”
Reference: Jeanna Mary Qiu, Mei Rosemary Fu, Catherine S. Finlayson, Charles P. Tilley, Rubén Martín Payo, Stephanie Korth, Howard L. Kremer, Cynthia L. Russell Lippincott, Lymphatic pain in breast cancer survivors: An overview of the current evidence and recommendations, Women and Children Nursing, Volume 2, Issue 2, 2024, Pages 33-38, ISSN 2949-7515, https://doi.org/10.1016/j.wcn.2024.04.001.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.